DexCom, Inc. (DXCM) Stock Overview
Explore DexCom, Inc.’s financial performance, market position, analyst ratings, and future outlook.
DexCom, Inc. (DXCM)
Key Financials
Key Financials
Market Cap
32.7B
P/E Ratio
33.39
EPS (TTM)
$2.55
ROE
0.36%
DXCM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of DexCom, Inc. (NASDAQ: DXCM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, DexCom, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DXCM on the NASDAQ shows an RSI of 48.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $68.89 for the NASDAQ listing.
Key metrics behind DexCom, Inc.'s NASDAQ-traded stock include a P/E ratio of 33.39 and a market capitalization of 32.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DXCM on the NASDAQ.